DD151751A5 - Verfahren zur herstellung von schwefelhaltigen isochinolinderivaten - Google Patents

Verfahren zur herstellung von schwefelhaltigen isochinolinderivaten Download PDF

Info

Publication number
DD151751A5
DD151751A5 DD80222310A DD22231080A DD151751A5 DD 151751 A5 DD151751 A5 DD 151751A5 DD 80222310 A DD80222310 A DD 80222310A DD 22231080 A DD22231080 A DD 22231080A DD 151751 A5 DD151751 A5 DD 151751A5
Authority
DD
German Democratic Republic
Prior art keywords
general formula
meanings given
point
isoquinoline
dashed line
Prior art date
Application number
DD80222310A
Other languages
German (de)
English (en)
Inventor
Kalman Takacs
Maria H Pap
Gabor Kovacs
Ilona K Ajzert
Antal Simay
Peter Literati-Nagy
Marian E Puskas
Gyula Sebestyen
Istvan Stadler
Zoltan Suemeghy
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of DD151751A5 publication Critical patent/DD151751A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DD80222310A 1979-07-02 1980-07-01 Verfahren zur herstellung von schwefelhaltigen isochinolinderivaten DD151751A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79CI1944A HU178454B (en) 1979-07-02 1979-07-02 Process for preparing new isoquinoline derivatives containing sulphur

Publications (1)

Publication Number Publication Date
DD151751A5 true DD151751A5 (de) 1981-11-04

Family

ID=10994753

Family Applications (1)

Application Number Title Priority Date Filing Date
DD80222310A DD151751A5 (de) 1979-07-02 1980-07-01 Verfahren zur herstellung von schwefelhaltigen isochinolinderivaten

Country Status (26)

Country Link
US (1) US4373104A (xx)
JP (1) JPS5649365A (xx)
AT (1) AT376664B (xx)
AU (1) AU534697B2 (xx)
BE (1) BE884101A (xx)
BG (2) BG36934A3 (xx)
CH (1) CH651554A5 (xx)
CS (2) CS221811B2 (xx)
DD (1) DD151751A5 (xx)
DE (1) DE3023717A1 (xx)
DK (1) DK160422C (xx)
ES (1) ES8105715A1 (xx)
FI (1) FI76324C (xx)
FR (1) FR2460934A1 (xx)
GB (1) GB2053914B (xx)
GR (1) GR69299B (xx)
HU (1) HU178454B (xx)
IL (1) IL60408A (xx)
IN (1) IN151448B (xx)
NL (1) NL190700C (xx)
NO (1) NO155539C (xx)
PL (2) PL126804B1 (xx)
PT (1) PT71472A (xx)
SE (1) SE455701B (xx)
SU (2) SU936809A3 (xx)
YU (1) YU170480A (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
HU189764B (en) * 1983-10-25 1986-07-28 Richter Gedeon Vegyeszeti Gyar Rt,Hu Process for preparing 1-(bis (substituted methyl)-methyl)-isoquinoline-derivatives
HU189765B (en) * 1983-10-25 1986-07-28 Richter Gedeon Vegyeszeti Gyar Rt,Hu Process for preparing n-substituted 1-(bis (hydroxy-metiol)-methyl)-isoquinoline-derivatives
US4584379A (en) * 1985-01-22 1986-04-22 Merrell Dow Pharmaceuticals Inc. Isoquinoline thromboxane synthetase inhibitors
JPS63236994A (ja) * 1987-03-26 1988-10-03 株式会社三協精機製作所 シ−ルド部材
HU209930B (en) * 1990-11-14 1994-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing of 2-mercapto-2-(1-isoquinolylidene)-acetonitrile derivatives and pharmaceutical compositions comprising them
DE4343683A1 (de) * 1993-12-21 1995-06-22 Boehringer Ingelheim Kg Anellierte Dihydropyridine und deren Verwendung für die Herstellung von pharmazeutischen Zubereitungen
HUP0000920A3 (en) * 2000-02-28 2002-03-28 Sanofi Synthelabo Pde4 inhibitor isoquinolinylidene derivatives, process for their preparation and medicaments containing them

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2985649A (en) * 1959-09-17 1961-05-23 Pfizer & Co C Derivatives of thiabenzopyrrocoline, thiabenzopyridocoline and thiazepine
GB1145254A (en) * 1965-03-18 1969-03-12 Bristol Myers Co Novel tetrahydroisoquinoline derivatives and a process for the preparation thereof
GB1127525A (en) * 1966-04-01 1968-09-18 Pfizer Ltd Di- and tetrahydroisoquinoline derivatives
US3389141A (en) * 1966-05-16 1968-06-18 Bristol Myers Co 1-beta-aryloxyethyltetrahydro-isoquinolines
US3389140A (en) * 1966-05-16 1968-06-18 Bristol Myers Co 1-beta-arylaminoethyl-2-methyl-6, 7-dimethoxy-1, 2, 3, 4-tetrahydroisoquinolines
US3455933A (en) * 1966-11-15 1969-07-15 American Home Prod Thiazolo and thiazino isoquinoline derivatives
JPS5516138B2 (xx) * 1971-11-17 1980-04-30
FR2119989B1 (xx) * 1970-12-29 1975-10-10 Fujisawa Pharmaceutical Co
AT333763B (de) * 1972-06-20 1976-12-10 Fujisawa Pharmaceutical Co Verfahren zur herstellung von neuen 1,2,3,4-tetrahydroisochinolinen und deren salzen
HU170680B (xx) * 1973-05-30 1977-08-28
AT351540B (de) * 1974-07-17 1979-07-25 Fujisawa Pharmaceutical Co Verfahren zur herstellung von neuen tetrahydro- isochinolinderivaten und deren salzen

Also Published As

Publication number Publication date
PL126804B1 (en) 1983-08-31
DK160422C (da) 1991-08-19
DK160422B (da) 1991-03-11
NL8003803A (nl) 1981-01-06
FR2460934B1 (xx) 1984-12-21
ES493569A0 (es) 1981-07-01
ATA334880A (de) 1984-05-15
AT376664B (de) 1984-12-27
AU6000180A (en) 1981-02-05
PL124602B1 (en) 1983-02-28
JPH0131502B2 (xx) 1989-06-26
PL225380A1 (xx) 1981-10-02
ES8105715A1 (es) 1981-09-01
BG36631A3 (en) 1984-12-16
FI802093A (fi) 1981-01-03
IN151448B (xx) 1983-04-23
CS221811B2 (en) 1983-04-29
AU534697B2 (en) 1984-02-09
JPS5649365A (en) 1981-05-02
PL230938A1 (xx) 1982-03-15
US4373104A (en) 1983-02-08
SE455701B (sv) 1988-08-01
NO155539C (no) 1987-04-15
SU936809A3 (ru) 1982-06-15
FR2460934A1 (fr) 1981-01-30
NO155539B (no) 1987-01-05
IL60408A (en) 1984-11-30
SE8004869L (sv) 1981-01-03
NO801982L (no) 1981-01-05
NL190700B (nl) 1994-02-01
BG36934A3 (en) 1985-02-15
HU178454B (en) 1982-05-28
CH651554A5 (de) 1985-09-30
GR69299B (xx) 1982-05-13
SU1047389A3 (ru) 1983-10-07
DK284880A (da) 1981-01-03
BE884101A (fr) 1980-11-03
YU170480A (en) 1983-06-30
GB2053914A (en) 1981-02-11
DE3023717C2 (xx) 1991-03-21
CS221810B2 (en) 1983-04-29
DE3023717A1 (de) 1981-01-29
NL190700C (nl) 1994-07-01
PT71472A (en) 1980-07-01
FI76324C (fi) 1988-10-10
GB2053914B (en) 1983-04-27
FI76324B (fi) 1988-06-30

Similar Documents

Publication Publication Date Title
DE2915318C2 (xx)
DE2366106B1 (de) 2-Amino-6,7-dimethoxy-4-(methoxysubstituierte-1,2,3,4-tetrahydroisochinolin-2-yl)-chinazolinderivate,Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
WO1991017991A1 (de) Neue sulfonylverbindungen
EP0174654A2 (de) Carbonylverbindungen
CH646696A5 (de) Dibenzazepine, ihre herstellung und verwendung.
DD151751A5 (de) Verfahren zur herstellung von schwefelhaltigen isochinolinderivaten
DE2362553A1 (de) Neue piperazinderivate
DE3028001A1 (de) Neue, in 5-stellung substituierte 5,10-dihydro-11h-dibenzo (b,e)(1,4) diazepin-11-one, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel
EP0085899B1 (de) Neue Pyridobenzodiazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH646702A5 (de) Pyridothienotriazine, verfahren zu ihrer herstellung und sie enthaltende antiallergiemittel.
DD300105A5 (de) Neue R(-)3-Quinuliclidinol - Derivate
DE3204157A1 (de) Substituierte dibenzodiazepinone, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE3542661A1 (de) Imidazopyridazinalkensaeureamide, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung
CH616934A5 (en) Process for the preparation of chromone derivatives
DE3204153A1 (de) Substituierte thienobenzodiazepinone, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
EP0233483A2 (de) Pyrrolo[1,2-a][4,1]benzoxazepine, Verfahren zur ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie therapeutische Verwendung
DE3874465T2 (de) 1,2,3,4-tetrahydroisochonoline als antiarrhythmische mittel.
DE2359359B2 (de) Fluor-substituierte thioxanthene, verfahren zu ihrer herstellung sowie diese enthaltende neuroleptische mittel
DE2435381C2 (de) 8-(2-Dimethylaminoäthyl)-3-oxo-4-phenyl-1-thia-4,8-diazaspiro[4.5]decan und seine Salze mit Säuren, Verfahren zu ihrer Herstellung und deren Verwendung in Arzneipräparaten
DE2828528A1 (de) 1-oxo-1,2-dihydroisochinolinderivate
DE1620368A1 (de) Verfahren zur Herstellung neuer heterocyclischer Verbindungen
DE2549901A1 (de) 1,2,3,4-tetrahydroisochinoline, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel
DE2614836A1 (de) Neue chromonverbindungen, verfahren zu ihrer herstellung und sie enthaltende arzneimittelzubereitungen
DE1445845C (de) 5-Phenyl-6,7-benzomorphane
CH660011A5 (de) Substituierte carboxy-thiazolo-(3,2-a)-pyrimidin-derivate.

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee